Clinical Chemistry AACC Online Job Center
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Clinical Chemistry 38: 1737-1742, 1992;
This Article
Right arrow Full Text (PDF)
Right arrow Submit an electronic Letter to
the Editor about this paper
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Vaidya, H. C.
Right arrow Articles by Beatty, B. G.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Vaidya, H. C.
Right arrow Articles by Beatty, B. G.

Clinical Chemistry, Vol 38, 1737-1742, Copyright © 1992 by American Association for Clinical Chemistry

Eliminating interference from heterophilic antibodies in a two-site immunoassay for creatine kinase MB by using F(ab')2 conjugate and polyclonal mouse IgG

HC Vaidya and BG Beatty
E. I. du Pont de Nemours and Company, Inc., Medical Products, Diagnostics Systems R&D Division, Glasgow Research Laboratory, Newark, DE 19714-6101.

Heterophilic antibodies interfere in two-site immunoassays. Our purpose was to screen for the samples containing heterophilic antibodies that react with mouse immunoglobulins and to use them to determine how to eliminate interference in various two-site immunoassays being developed in our laboratory. Of approximately 2600 samples screened, 81 had heterophilic antibodies. When creatine kinase MB (CKMB) concentration was measured with intact antibody conjugate in these 81 samples, 18 (22%) samples had apparent CKMB values significantly greater than values measured with Hybritech's "Tandem -E CKMB immunoenzymetric" assay and Corning agarose-gel electrophoresis. Adding up to 133 mg/L of polymerized IgG or up to 1666 mg/L polyclonal mouse IgG in the assay did not eliminate the interference in all the samples. However, adding F(ab')2 conjugate plus 40 mg/L of polymerized IgG or 83 mg/L of polyclonal mouse IgG eliminated the interference in all the samples. This approach was also effective in eliminating the interference in 15 samples containing 4.7-165.2 mg/L of human antimouse antibody (HAMA). Combined use of F(ab')2 conjugate and polyclonal mouse IgG is recommended to eliminate interference from heterophilic antibodies that react with murine immunoglobulins or HAMA in two-site murine-antibody- based assays.


The following articles in journals at HighWire Press have cited this article:


Home page
Clin. Chem.Home page
D. J. Warren, J. Bjerner, E. Paus, O. P. Bormer, and K. Nustad
Use of an In Vivo Biotinylated Single-Chain Antibody as Capture Reagent in an Immunometric Assay to Decrease the Incidence of Interference from Heterophilic Antibodies
Clin. Chem., May 1, 2005; 51(5): 830 - 838.
[Abstract] [Full Text] [PDF]


Home page
Clin. Chem.Home page
S. Eriksson, H. Halenius, K. Pulkki, J. Hellman, and K. Pettersson
Negative Interference in Cardiac Troponin I Immunoassays by Circulating Troponin Autoantibodies
Clin. Chem., May 1, 2005; 51(5): 839 - 847.
[Abstract] [Full Text] [PDF]


Home page
Clin. Chem.Home page
J. Bjerner, O. P. Bormer, and K. Nustad
The War on Heterophilic Antibody Interference
Clin. Chem., January 1, 2005; 51(1): 9 - 11.
[Full Text] [PDF]


Home page
ChestHome page
C. Roongsritong, I. Warraich, and C. Bradley
Common Causes of Troponin Elevations in the Absence of Acute Myocardial Infarction: Incidence and Clinical Significance
Chest, May 1, 2004; 125(5): 1877 - 1884.
[Abstract] [Full Text] [PDF]


Home page
Clin. Chem.Home page
S. Eriksson, M. Junikka, P. Laitinen, K. Majamaa-Voltti, H. Alfthan, and K. Pettersson
Negative Interference in Cardiac Troponin I Immunoassays from a Frequently Occurring Serum and Plasma Component
Clin. Chem., July 1, 2003; 49(7): 1095 - 1104.
[Abstract] [Full Text] [PDF]


Home page
Clin. Chem.Home page
F. Flourie, F. Parant, M. C. Penes, and D. Alcaraz-Galvain
Falsely Increased Thyroid-stimulating Hormone Concentrations attributable to Interference from Human Anti-mouse Antibodies
Clin. Chem., December 1, 2002; 48(12): 2289 - 2289.
[Full Text] [PDF]


Home page
Annals of Clinical & Laboratory ScienceHome page
R. L. Bertholf, L. Johannsen, and G. Benrubi
False Elevation of Serum CA-125 Level Caused by Human Anti-Mouse Antibodies
Ann. Clin. Lab. Sci., October 1, 2002; 32(4): 414 - 418.
[Abstract] [Full Text] [PDF]


Home page
Clin. Chem.Home page
W. J. Kim, O. F. Laterza, K. G. Hock, J. F. Pierson-Perry, D. M. Kaminski, M. Mesguich, F. Braconnier, R. Zimmermann, M. Zaninotto, M. Plebani, et al.
Performance of a Revised Cardiac Troponin Method That Minimizes Interferences from Heterophilic Antibodies
Clin. Chem., July 1, 2002; 48(7): 1028 - 1034.
[Abstract] [Full Text] [PDF]


Home page
Clin. Chem.Home page
J. Bjerner, K. Nustad, L. F. Norum, K. H. Olsen, and O. P. Bormer
Immunometric Assay Interference: Incidence and Prevention
Clin. Chem., April 1, 2002; 48(4): 613 - 621.
[Abstract] [Full Text] [PDF]


Home page
Clin. Chem.Home page
M. Covinsky, O. Laterza, J. D. Pfeifer, T. Farkas-Szallasi, and M. G. Scott
An IgM {lambda} Antibody to Escherichia coli Produces False-Positive Results in Multiple Immunometric Assays
Clin. Chem., August 1, 2000; 46(8): 1157 - 1161.
[Abstract] [Full Text] [PDF]


Home page
Clin. Chem.Home page
S. Eriksson, M. Vehniainen, T. Jansen, V. Meretoja, P. Saviranta, K. Pettersson, and T. Lovgren
Dual-Label Time-resolved Immunofluorometric Assay of Free and Total Prostate-specific Antigen Based on Recombinant Fab Fragments
Clin. Chem., May 1, 2000; 46(5): 658 - 666.
[Abstract] [Full Text] [PDF]


Home page
Clin. Chem.Home page
L. J. Kricka
Human Anti-Animal Antibody Interferences in Immunological Assays
Clin. Chem., July 1, 1999; 45(7): 942 - 956.
[Abstract] [Full Text] [PDF]


Home page
Clin. Chem.Home page
I. V. Kaplan and S. S. Levinson
When Is a Heterophile Antibody Not a Heterophile Antibody? When It Is an Antibody against a Specific Immunogen
Clin. Chem., May 1, 1999; 45(5): 616 - 618.
[Abstract] [Full Text] [PDF]


Home page
Clin. Chem.Home page
T. Q. Wei, V. P. Chu, A. R. Craig, J. E. Duffy, D. M. Obzansky, D. Kilgore, I. S. Masulli, C. M. Sanders, and J. C. Thompson
Automated Homogeneous Immunoassay for Gentamicin on the Dimension Clinical Chemistry System
Clin. Chem., March 1, 1999; 45(3): 388 - 393.
[Abstract] [Full Text] [PDF]


Home page
Clin. Chem.Home page
J. Reinsberg
Interferences with Two-site Immunoassays by Human Anti-mouse Antibodies Formed by Patients Treated with Monoclonal Antibodies: Comparison of Different Blocking Reagents
Clin. Chem., August 1, 1998; 44(8): 1742 - 1744.
[Full Text] [PDF]


Home page
Clin. Chem.Home page
N. Despres and A. M. Grant
Antibody interference in thyroid assays: a potential for clinical misinformation
Clin. Chem., March 1, 1998; 44(3): 440 - 454.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 1992 by the American Association for Clinical Chemistry.